Cargando…
Advanced Imaging Techniques for Differentiating Pseudoprogression and Tumor Recurrence After Immunotherapy for Glioblastoma
Glioblastoma (GBM) is the most common malignant tumor of the central nervous system with poor prognosis. Although the field of immunotherapy in glioma is developing rapidly, glioblastoma is still prone to recurrence under strong immune intervention. The major challenges in the process of immunothera...
Autores principales: | Li, Yan, Ma, Yiqi, Wu, Zijun, Xie, Ruoxi, Zeng, Fanxin, Cai, Huawei, Lui, Su, Song, Bin, Chen, Lei, Wu, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656432/ https://www.ncbi.nlm.nih.gov/pubmed/34899760 http://dx.doi.org/10.3389/fimmu.2021.790674 |
Ejemplares similares
-
Tumor Mutational Burden Predicting the Efficacy of Immune Checkpoint Inhibitors in Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Li, Yan, et al.
Publicado: (2021) -
Retro-enantio isomer of angiopep-2 assists nanoprobes across the blood-brain barrier for targeted magnetic resonance/fluorescence imaging of glioblastoma
por: Xie, Ruoxi, et al.
Publicado: (2021) -
Assessment of immunotherapy response in intracranial malignancy using semi-automatic segmentation on magnetic resonance images
por: Tan, Jia, et al.
Publicado: (2022) -
Pseudoprogression and Immunotherapy Phenomena
por: Waxman, Elizabeth S., et al.
Publicado: (2020) -
Advances in immunotherapy for glioblastoma multiforme
por: Mahmoud, Ahmad Bakur, et al.
Publicado: (2022)